Skip to main content

Table 3 Age adjusted prevalence of pre-diabetes and diabetes by residence, wealth status and region, STEPS survey

From: Prevalence and factors associated with pre-diabetes and diabetes mellitus in Kenya: results from a national survey

Indicator Diabetes
(% [95%CI])
Pre-diabetes
(% [95%CI])
Diabetes awareness
(% [95%CI])
Diabetes treatment (% [95%CI]) Diabetes control (% [95%CI])
National 2.4 [01.8:03.0] 03.1 [02.2:04.0] 43.7 [29.1:59.5] 21.3 [12.0:35.1] 07.0 [03.6:13.2]
Residence      
 Rural 1.9 [01.3:02.5] 02.7 [01.8:03.7] 39.5 [25.2:55.7] 14.9 [08.6:24.6] 07.7 [03.3:17.1]
 Urban 3.4 [02.1:04.7] 03.5 [01.6:05.3] 48.6 [22.4:75.6] 28.7 [11.1:56.4] 06.2 [02.2:16.2]
Wealth status      
 1 - Poorest 1.6 [00.7:02.5] 03.3 [01.1:05.5] 17.8 [04.0:52.9] 00.0 [00.0:00.0] 00.0 [00.0:00.0]
 2 1.5 [00.7:02.2] 02.3 [01.1:03.4] 53.0 [27.1:77.3] 23.1 [08.7:48.7] 13.2 [03.8:37.1]
 3 2.0 [01.1:02.9] 03.0 [01.4:04.6] 32.5 [16.2:54.5] 28.4 [13.3:50.7] 17.6 [06.8:38.5]
 4 3.0 [01.8:04.3] 01.6 [00.7:02.6] 49.5 [23.7:75.5] 33.2 [10.3:68.2] 02.5 [00.6:09.8]
 5 - Richest 5.2 [02.5:07.9] 04.9 [01.4:08.4] 52.9 [16.5:86.5] 16.0 [04.5:43.4] 04.5 [00.9:19.2]
Sex      
 Female 2.8 [02.0:03.6] 03.3 [02.2:04.4] 44.9 [28.6:62.4] 33.7 [19.8:51.3] 10.5 [05.4:19.6]
 Male 2.0 [01.1:02.9] 02.8 [01.6:04.1] 42.0 [21.8:65.2] 03.5 [01.1:10.6] 01.9 [00.3:09.7]
Age (years)      
 18–29 0.6 [00.3;01.4] 02.1 [01.1;03.8] 27.8 [05.8:70.6] 08.2 [01.6:32.8] 05.3 [00.6:32.7]
 30–44 2.3 [01.5;03.5] 02.9 [02.0;04.2] 21.7 [09.2:43.0] 16.1 [06.7:34.1] 09.0 [02.9:24.5]
 45–59 7.1 [04.8;10.3] 05.3 [03.5;07.8] 54.9 [32.0:75.9] 28.5 [12.2:53.2] 06.0 [02.2:15.3]
 60–69 6.0 [03.7;09.5] 06.4 [03.9;10.2] 70.1 [45.7:86.8] 20.1 [08.0:42.2] 07.5 [02.4:21.2]
Total (N) 4069 3934 135 135 135
  1. NB: Awareness, treatment and control estimates are not age adjusted. Awareness was defined as prior diagnosis of diabetes by a healthcare professional among diabetic participants. Treatment was defined as receiving pharmacologic treatment to lower blood glucose in the previous 2 weeks among diabetic participants. Control was defined as having a fasting blood glucose of < 7 mmol/l while on pharmacologic treatment among diabetic participants